Nectar Lifesciences 31st AGM minutes filed; all 5 resolutions passed

Board & Shareholder Meetings View source PDF Explain this filing

NECLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.7%Reaction day

₹10.21

prior close

₹10.40

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.0%+2.7% vs market

On the reaction day the stock moved 2.7 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

-0.1

30m

-1.0

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

+2.7+0.0+2.7

Next day

+7.7+1.3+6.4

+4.2+1.1+3.1

+3.7-1.7+5.4

-0.5-1.4+1.0

-0.9-0.6-0.3

-1.1+0.3-1.4

15d

+3.5-6.1+9.6

-0.1-3.1+3.0

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Nectar Lifesciences filed minutes of its 31st AGM held on Sept 18, 2026 via video conferencing with 49 members present. All 5 resolutions passed with over 99.97% majority. Resolutions covered: adoption of FY26 financial statements, re-appointment of CMD Sanjiv Goyal by rotation, re-appointment of Independent Directors Dr. Kuldip Bhasin and Dr. Indu Pal Kaur for a second 5-year term, and appointment of Dr. Gunmala Suri as Non-Executive Director. Statutory auditors gave an unqualified opinion with no adverse comments.

Likely market impact

Routine filing. All 5 resolutions passed easily; retail shareholders voted against some director appointments, but promoter group holds around 99% of voting power.